R.A. Rojer

693 total citations
16 papers, 518 citations indexed

About

R.A. Rojer is a scholar working on Genetics, Hematology and Physiology. According to data from OpenAlex, R.A. Rojer has authored 16 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Hematology and 4 papers in Physiology. Recurrent topics in R.A. Rojer's work include Hemoglobinopathies and Related Disorders (13 papers), Blood groups and transfusion (8 papers) and Iron Metabolism and Disorders (7 papers). R.A. Rojer is often cited by papers focused on Hemoglobinopathies and Related Disorders (13 papers), Blood groups and transfusion (8 papers) and Iron Metabolism and Disorders (7 papers). R.A. Rojer collaborates with scholars based in Netherlands and Curacao. R.A. Rojer's co-authors include Ashley J. Duits, John‐John B. Schnog, Dees P. M. Brandjes, Hugo Ten Cate, Frits A.J. Muskiet, A.W. Saleh, Leroy R. Lard, Kenrick Berend, Melvin R. Mac Gillavry and Hilga Katerberg and has published in prestigious journals such as The American Journal of Medicine, British Journal of Haematology and Clinical Immunology.

In The Last Decade

R.A. Rojer

16 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.A. Rojer Netherlands 10 432 324 107 58 48 16 518
Majid Yavarian Iran 12 441 1.0× 387 1.2× 55 0.5× 91 1.6× 118 2.5× 51 625
Alexandra Stamoulakatou Greece 18 717 1.7× 656 2.0× 144 1.3× 83 1.4× 139 2.9× 44 901
María de Fátima Sonati Brazil 14 537 1.2× 457 1.4× 90 0.8× 103 1.8× 200 4.2× 83 720
Simone Cristina Olenscki Gilli Brazil 13 264 0.6× 315 1.0× 134 1.3× 43 0.7× 56 1.2× 31 475
JULIAN R. DAVIS United States 5 385 0.9× 305 0.9× 60 0.6× 57 1.0× 89 1.9× 7 458
André Rolim Belisário Brazil 12 273 0.6× 257 0.8× 25 0.2× 58 1.0× 82 1.7× 45 374
Beatrice E. Gee United States 12 886 2.1× 759 2.3× 108 1.0× 127 2.2× 190 4.0× 36 1000
Beatrice Files United States 9 396 0.9× 347 1.1× 50 0.5× 37 0.6× 137 2.9× 15 464
Paolo Rigano Italy 17 450 1.0× 367 1.1× 52 0.5× 61 1.1× 121 2.5× 33 524
Harold M. Koenig United States 10 288 0.7× 246 0.8× 54 0.5× 76 1.3× 118 2.5× 26 467

Countries citing papers authored by R.A. Rojer

Since Specialization
Citations

This map shows the geographic impact of R.A. Rojer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.A. Rojer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.A. Rojer more than expected).

Fields of papers citing papers by R.A. Rojer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.A. Rojer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.A. Rojer. The network helps show where R.A. Rojer may publish in the future.

Co-authorship network of co-authors of R.A. Rojer

This figure shows the co-authorship network connecting the top 25 collaborators of R.A. Rojer. A scholar is included among the top collaborators of R.A. Rojer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.A. Rojer. R.A. Rojer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Schnog, John‐John B., Melvin R. Mac Gillavry, Anton P. van Zanten, et al.. (2004). Protein C and S and inflammation in sickle cell disease. American Journal of Hematology. 76(1). 26–32. 33 indexed citations
2.
Schnog, John‐John B., Ashley J. Duits, Frits A.J. Muskiet, et al.. (2004). Sickle cell disease; a general overview.. PubMed. 62(10). 364–74. 116 indexed citations
3.
Duits, Ashley J., R.A. Rojer, Melvin R. Mac Gillavry, et al.. (2003). Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease. Annals of Hematology. 82(3). 171–174. 16 indexed citations
4.
Schnog, John‐John B., R.A. Rojer, Melvin R. Mac Gillavry, et al.. (2003). Steady-state sVCAM-1 serum levels in adults with sickle cell disease. Annals of Hematology. 82(2). 109–113. 28 indexed citations
5.
Schnog, John‐John B., Melvin R. Mac Gillavry, R.A. Rojer, et al.. (2002). No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease. American Journal of Hematology. 71(1). 53–55. 8 indexed citations
6.
Schnog, John‐John B., Arnon P. Kater, Melvin R. Mac Gillavry, et al.. (2001). Low adjusted‐dose acenocoumarol therapy in sickle cell disease: A pilot study. American Journal of Hematology. 68(3). 179–183. 29 indexed citations
7.
Schnog, John‐John B., et al.. (2000). Duffy Phenotype Does Not Influence the Clinical Severity of Sickle Cell Disease. Clinical Immunology. 96(3). 264–268. 9 indexed citations
8.
Schnog, John‐John B., Leroy R. Lard, R.A. Rojer, et al.. (1998). New concepts in assessing sickle cell disease severity. American Journal of Hematology. 58(1). 61–66. 42 indexed citations
9.
Duits, Ashley J., John‐John B. Schnog, Leroy R. Lard, A.W. Saleh, & R.A. Rojer. (1998). Elevated IL‐8 levels during sickle cell crisis. European Journal Of Haematology. 61(5). 302–305. 62 indexed citations
10.
Schnog, John‐John B., et al.. (1998). New concepts in assessing sickle cell disease severity. American Journal of Hematology. 58(1). 61–66. 4 indexed citations
11.
Duits, Ashley J., R. Pieters, A.W. Saleh, et al.. (1996). Enhanced Levels of Soluble VCAM-1 in Sickle Cell Patients and Their Specific Increment during Vasoocclusive Crisis. Clinical Immunology and Immunopathology. 81(1). 96–98. 105 indexed citations
12.
Rojer, R.A., et al.. (1995). Prophylaxis of delayed nausea and vomiting after cancer chemotherapy. The Netherlands Journal of Medicine. 47(1). 12–17. 9 indexed citations
13.
Daenen, Simon, R.A. Rojer, Johannes W. A. Smit, M. R. Halie, & H. O. Nieweg. (1984). Successful chemotherapy with deoxycoformycin in adult T‐cell lymphoma‐leukaemia. British Journal of Haematology. 58(4). 723–727. 38 indexed citations
14.
Rojer, R.A., Nanno H. Mulder, & H. O. Nieweg. (1978). ‘Classic’ and ‘Acute’ Myelofibrosis. Acta Haematologica. 60(2). 108–116. 6 indexed citations
15.
Rojer, R.A., Nanno H. Mulder, H. O. Nieweg, et al.. (1978). Analysis of Extramedullary Erythropoiesis in the Spleen by a Semiquantitative Method Using Indium‐111. Acta Medica Scandinavica. 203(1-6). 481–486. 4 indexed citations
16.
Rojer, R.A., Nanno H. Mulder, & H. O. Nieweg. (1978). Response to pyridoxine hydrochloride in refractory anemia due to myelofibrosis. The American Journal of Medicine. 65(4). 655–660. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026